BY PATRICK COX
About a billion people lack enough water to meet their basic health and agricultural needs. Water-borne diseases cause nearly half of hospitalizations globally and kill millions each year.
Aquifers around the world are being depleted. The lack of clean water fuels conflicts and threatens economic growth from California to the Middle East.
As peak oil fears fade, water has emerged as the next resource crisis. While water supplies have always been huge, the cost to purify water (including waste and sea water) is too high to help the areas that need it most.
I’m convinced, though, that a solution has been found. And experts at the Department of Energy and the National Science Foundation agree. The technology does not use standard polymeric membranes or even graphene. Rather, it comes from drug development biotechnologies honed by the pharmaceutical industry.
Pharmaceutical science approaches water in a new way
Agua Via controls this technology. The company has found a way to mimic the super-efficient biological membranes that are in your body. It uses the same development technologies that make the drugs in your medicine cabinet.
This biomimetic process could cut the cost of water purification by at least a factor of ten. In the long run, the price tag of desalinization could decrease to 1% of current costs.
Agua Via has struggled to explain its breakthrough to conventional polymeric membrane chemists. This is because the industry relies on a technology that is almost 50 years old. Agua Via’s new approach uses a science far outside the industry’s expertise (polymer filters that use more energy when removing smaller contaminants).
The chief scientist behind Agua Via’s breakthroughs, Martin Edelstein PhD, is an organic chemist. He also has a long history in the pharmaceutical business. His approach to water purification was informed by an industry that makes molecularly precise materials using the same principles of organic chemistry that our bodies do.
Nanotechnology and water purification
The term “molecularly precise manufacturing” tends to be associated with nanotechnology. Scientists who work at this scale aspire to build with individual atoms. They work “top down,” trying to make large structures ever smaller.
But, drug makers already do atomically precise manufacturing. In the drug business, a single out-of-place atom in a drug molecule is not just a mistake… it can be lethal. In the cut-throat world of drug companies, they’ve learned to be both precise and cost efficient. Nanotechnologists can only do so at a much greater cost.
The building blocks of Agua Via’s technology are 150 atom “pores.” Each is the equivalent of a complex pharmaceutical. The pores, floating in perfectly still water, are coaxed to self-assemble into precise molecular configurations to create a one atomic layer thick membrane. This is done by manipulating the covalent bonding forces that hold molecules together.
The company can design these configurations with attachment points on their sides and tops. Many of them tessellate. This means they self-assemble into stable geometric patterns like those seen in quilting and some M.C. Escher illustrations. The result is a durable, large single-molecule thick structure. It can then be integrated onto strong but porous polymer films, which makes it even stronger.
These molecularly precise films have one critical trait due to their molecular scale. The pores can be made with precise shapes, sizes, charges, and other chemical attributes. This creates membranes that can control what passes through them. So far, the company has patented over 20 million holes that occur in tessellating self-assembling nanomembranes.
The list of potential uses is immense. The most obvious is water purification. So Edelstein and cofounder Gayle Pergamit studied the water purification industry. They found that the industry’s approach ignored biomimetic advantages to solve problems.
Their vision was a nanomembrane that would allow only the desirable molecules found in water to pass through. This would occur no matter what was in the untreated source. While this may seem like a big stretch, it’s happening right now in your body… in every membrane of every cell.
The human body provides a key to water filtration
Prior to 2003, it was thought that water in cells diffused through normal forces. But Peter Agre, PhD changed that. He won the Nobel Prize in Chemistry for his discovery of cellular water channels. He called them aquaporins.
Agre described biological structures (channels comprising pores) that rapidly move water but not unwanted impurities. This process is so fast that some scientists have described it as “water teleportation.”
Clearly, this process happens in the body without multiple membranes or high energy expenditures. So the Agua Via team designed a nanomembrane that replicated only the critical part of aquaporins. Though they lacked the resources to scale up their design, small scale tests showed the same sort of purification results found in our cells. Of course, almost no one with a conventional polymer chemistry background believed them.
One man who did not dismiss the idea was former secretary of state George Schultz. Schultz has long thought that conflict over scarce water resources is a major cause of war and strife. So he took the company’s science to a biochemist friend Paul Berg PhD. Berg is the Nobel laureate who pioneered genetic engineering in 1970 and helped launch the biotech success story Genentech.
Berg was one of the few people with the background and vision to understand the science behind the project. It also helped that when he was younger, he worked with the Office of Naval Research on desalinization technologies. He gave his endorsement to Schultz, who continues to be a strong supporter and is now an investor.
The US government endorses this breakthrough
For years, I’ve watched this technology languish. But the right connections have now been made… some through George Shultz and some through US and international leaders in the field of water.
Scientists at the Department of Energy and the National Science Foundation have studied the process and see its great potential. The technology has been given a phase 2 Department of Energy award to develop massively parallel nanomembrane manufacturing. It also earned a National Science Foundation phase 1 award for prototyping a real-time quality control system on the manufacturing line.
The company has already signed contracts with major water suppliers. And I expect there will soon be other grants and awards.
Many experts in the water industry have now reviewed Agua Via’s technology. They want to help the company turn the process into a reality. If things go well, the global water crisis may join peak oil as a former problem in as little as five years.
Stay in the Loop on Life-Extending Research with Patrick Cox's Tech Digest
This weekly newsletter by biotech expert Patrick Cox highlights research that is much more advanced than most people know, and the profit potential for investors is vast. Read about the latest breakthroughs—from new, non-invasive cancer treatments to age-reversing nutraceuticals and vaccines that kill any virus–as well as the innovative companies that work on them. Get Tech Digest free in your inbox every Monday.